BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 9328808)

  • 1. Integrating treatments for methamphetamine abuse: a psychosocial perspective.
    Huber A; Ling W; Shoptaw S; Gulati V; Brethen P; Rawson R
    J Addict Dis; 1997; 16(4):41-50. PubMed ID: 9328808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study.
    Petry NM; Peirce JM; Stitzer ML; Blaine J; Roll JM; Cohen A; Obert J; Killeen T; Saladin ME; Cowell M; Kirby KC; Sterling R; Royer-Malvestuto C; Hamilton J; Booth RE; Macdonald M; Liebert M; Rader L; Burns R; DiMaria J; Copersino M; Stabile PQ; Kolodner K; Li R
    Arch Gen Psychiatry; 2005 Oct; 62(10):1148-56. PubMed ID: 16203960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal methamphetamine smoking among regular ecstasy users in Australia: increases in use and associations with harm.
    Kinner SA; Degenhardt L
    Drug Alcohol Rev; 2008 May; 27(3):292-300. PubMed ID: 18368611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methamphetamine and cocaine users: differences in characteristics and treatment retention.
    Rawson R; Huber A; Brethen P; Obert J; Gulati V; Shoptaw S; Ling W
    J Psychoactive Drugs; 2000; 32(2):233-8. PubMed ID: 10908013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perpetrators of intimate partner violence use significantly more methamphetamine, cocaine, and alcohol than victims: a report by victims.
    Ernst AA; Weiss SJ; Enright-Smith S; Hilton E; Byrd EC
    Am J Emerg Med; 2008 Jun; 26(5):592-6. PubMed ID: 18534290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technology and innovation in the psychosocial treatment of methamphetamine use, risk and dependence.
    Kay-Lambkin FJ
    Drug Alcohol Rev; 2008 May; 27(3):318-25. PubMed ID: 18368614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk and protective factors for methamphetamine use and nonmedical use of prescription stimulants among young adults aged 18 to 25.
    Herman-Stahl MA; Krebs CP; Kroutil LA; Heller DC
    Addict Behav; 2007 May; 32(5):1003-15. PubMed ID: 16920275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics and harms associated with injecting versus smoking methamphetamine among methamphetamine treatment entrants.
    McKetin R; Ross J; Kelly E; Baker A; Lee N; Lubman DI; Mattick R
    Drug Alcohol Rev; 2008 May; 27(3):277-85. PubMed ID: 18368609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caries associated with methamphetamine abuse.
    Shaner JW
    J Mich Dent Assoc; 2002 Sep; 84(9):42-7. PubMed ID: 12271905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methamphetamine use and dental disease: results of a pilot study.
    Cretzmeyer M; Walker J; Hall JA; Arndt S
    J Dent Child (Chic); 2007; 74(2):85-92. PubMed ID: 18477425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methamphetamine use and HIV risk among substance-abusing offenders in California.
    Farabee D; Prendergast M; Cartier J
    J Psychoactive Drugs; 2002; 34(3):295-300. PubMed ID: 12422940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current data on methamphetamine].
    Cottencin O; Rolland B; Guardia D; Karila L
    Rev Prat; 2012 May; 62(5):679-81. PubMed ID: 22730802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute coronary syndrome and crystal methamphetamine use: a case series.
    Wijetunga M; Bhan R; Lindsay J; Karch S
    Hawaii Med J; 2004 Jan; 63(1):8-13, 25. PubMed ID: 15011896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methamphetamine use among young adults: health and social consequences.
    Sommers I; Baskin D; Baskin-Sommers A
    Addict Behav; 2006 Aug; 31(8):1469-76. PubMed ID: 16309848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is the self-report of recent cocaine or methamphetamine use reliable in illicit stimulant drug users who present to the Emergency Department with chest pain?
    Lee MO; Vivier PM; Diercks DB
    J Emerg Med; 2009 Aug; 37(2):237-41. PubMed ID: 19081702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methamphetamine abuse: an overview for health care professionals.
    Wolkoff DA
    Hawaii Med J; 1997 Feb; 56(2):34-6, 44. PubMed ID: 9063008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preface. Emerging targets and therapeutics in the treatment of psychostimulant abuse.
    Dwoskin LP
    Adv Pharmacol; 2014; 69():xi-xiii. PubMed ID: 24484989
    [No Abstract]   [Full Text] [Related]  

  • 18. Proposal for a bipolar-stimulant spectrum: temperament, diagnostic validation and therapeutic outcomes with mood stabilizers.
    Camacho A; Akiskal HS
    J Affect Disord; 2005 Mar; 85(1-2):217-30. PubMed ID: 15780692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Screening, by clinical observation, signs and symptoms of addiction to the use of general practice].
    Bertolini M
    Rev Med Suisse; 2011 Sep; 7(309):1789-90, 1792-3. PubMed ID: 22016932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An tale of two epidemics: HIV and stimulant use.
    Gorman M
    Focus; 1998 Mar; 13(4):1-3. PubMed ID: 11365170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.